Study to Assess Immune Responses and Safety of the GSK-580299 Vaccine in Healthy Women (26 to 45 Years)
Clinical trial NCT01277042 · COMPLETED
Trial details
- NCT number
- NCT01277042
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-17
- Primary completion
- 2011-09-26
- Enrollment
- 1212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.